Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
ANZ: If regional supply disruptions intensify and market buffers weaken, Brent crude could rise to US$120/barrel.
2026-07-24
ANZ: If regional supply disruptions intensify and market buffers weaken, Brent crude could rise to US$120/barrel.
Back
Other News
2026-07-24
A-share market opened: Shanghai Composite down 0.60%, Shenzhen Composite Index down 1.47%, ChiNext Index down 1.68%. Oilfield services/engineering and gas sectors outperformed; precious metals, MLCC, CPO, memory chips and PCB sectors opened lower.
A-share market opened: Shanghai Composite down 0.60%, Shenzhen Composite Index down 1.47%, ChiNext Index down 1.68%. Oilfield services/engineering and gas sectors outperformed; precious metals, MLCC, CPO, memory chips and PCB sectors opened lower.
2026-07-24
Qingdao’s government-guided city commercial-insurance product Qindao eBao updated and began sales on July 1, 2026, adding 10 drugs from the national first commercial-insurance innovative-drug catalog. Total special and rare-disease drugs covered rose
Qingdao’s government-guided city commercial-insurance product Qindao eBao updated and began sales on July 1, 2026, adding 10 drugs from the national first commercial-insurance innovative-drug catalog. Total special and rare-disease drugs covered rose to 33, including CAR-T and malignant tumor therapies. From July 1, 2025 to May 2026 Qindao eBao registered 8.48 mln policies, paid claims to 135,400 insureds totaling 936 mln yuan, of which specialty-drug payouts amounted to 108 mln yuan.
Chat with us
, powered by
LiveChat